Clicky

Covid

Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union

1200 277 Merci

The filing follows the European Medicines Agency’s Committee for Medicinal Products for Human Use recent decision to adopt a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine to include children six years of age and older.…

Bangladesh Society Recognizes COVID-19 Humanitarian Efforts Between United States and Bangladesh

1443 1056 Todd

Zahid F. Sarder Saddi has been involved in the Bangladeshi-American Community for over 25 years. He is an influential civil society leader who advocates for COVID-19 vaccine donations toward Bangladesh. NEW YORK, NY / ACCESSWIRE…

Altamira Therapeutics Announces Peer-Reviewed Publication on Positive in vitro Data with its Bentrio(TM) Drug-Free Nasal Spray Against SARS-CoV-2 Delta Variant

320 110 Merci

Study Confirms in vitro Efficacy / Safety of Bentrio(TM) for Delta Variant Prophylactic treatment of human nasal mucosa with Bentrio™ was reported to significantly reduce the viral titer vs. controls over 4 days, reaching a…

Net Medical Expands COVID Services With Clinical Trials for Manufacturers

2111 366 Merci

Leaning on two decades of experience connecting providers with the patients who need them, Net Medical’s business is unique and growing ALBUQUERQUE, NM / ACCESSWIRE / April 4, 2022 / Net Medical (OTC PINK:NMXS) announced today…

Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19

440 386 Robert

GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“ Relief “), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today…

Health Canada Authorizes Moderna’s COVID-19 Vaccine in Children (6-11 Years)

1200 277 Merci

CAMBRIDGE, MA / ACCESSWIRE / March 17, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Health Canada has approved the use of Moderna’s mRNA COVID-19…

Assistance for Long COVID Sufferers Targeted by Health Advance, Inc

335 434 Tori

NEW YORK, NY / ACCESSWIRE / March 17, 2022 / Health Advance, Inc (OTC PINK:HADV) www.HealthAdvanceGroup.com is launching a joint venture to supply new treatment options for the growing number of people internationally who are…

Altamira Therapeutics Receives Approval to Commence Clinical Trial Evaluating Bentrio in the Treatment of COVID-19

320 110 Merci

HAMILTON, BERMUDA / ACCESSWIRE / March 9, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its affiliate, Altamira Medica, has received the…

Halberd’s COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant

146 37 Merci

JACKSON CENTER, PA / ACCESSWIRE / March 1, 2022 / Halberd Corporation’s (OTC PINK:HALB) previously developed SARS-CoV-2 antibody demonstrated superior binding capability to the SARS-CoV-2 Omicron variant disease antigen. The Halberd antibody was tested against…

Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates

1200 277 Todd

Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29 Full year 2021 revenues of $18.5 billion; GAAP net-income of $12.2 billion and GAAP diluted EPS of $28.29…